Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Irisity Awarded 5th Year Renewal of Perimeter Security Contract in the UK

Gothenburg, Sweden – November 15th, 2024 – Irisity AB (publ), a provider of AI-driven video data management software, reports a renewal of a perimeter security contract with a UK-based home appliance manufacturer. It is an Annual Recurring Revenue (ARR) contract valued at more than MSEK 1.7, marking the fifth year of delivering a perimeter security SaaS deployment in partnership with a UK-based integration partner.  The contract began in November 2020, with yearly renewals. From an initial deployment of six cameras, the project continued to grow, expanding to 661 cameras by December 2023.

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 247 – 15 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

How to Play Online Bingo: A Beginner's Guide

Online bingo has become a popular pastime, offering the excitement of traditional bingo with the convenience of playing from home. If you're new to online bingo, this guide will help you get started and enjoy the game.Understanding the Basics At its core, bingo is a game of chance where players mark off numbers on a card as they are called out. The objective is to complete a specific pattern, such as a line or a full house, and be the first to complete the pattern and shout "Bingo!" to win. Understanding Bingo Cards In online bingo, you'll play with a digital bingo card. Each card

EQL Pharma's CBDO increases his holding in the company

EQL Pharma's Chief Business Development Officer (CBDO), Carl Lindgren, increases his shareholding in the company. On November 14[th], Carl Lindgren has bought 10,000 shares in the Company at an average price of SEK 60.00, a transaction totalling SEK 600,000. The trades were made outside the Stock Market and the shares were bought from the major owner Fårö Capital AB, related to Christer Fåhraeus who is Chairman of the board of EQL Pharma. After the purchases, Lindgren owns a total of 60,000 shares and 100,000 warrants in EQL Pharma."EQL is an entrepreneurial company in rapid and profitable

Cavendish Hydrogen ASA: Notice of extraordinary general meeting

Oslo, 15 November 2024: Based on a request from shareholders in accordance with section 5-7 (2) of the Norwegian Public Limited Liability Companies Act, the Board of Directors of Cavendish Hydrogen ASA ("Cavendish", OSE: CAVEN) calls for an extraordinary general meeting to be held on Friday, 6 December 2024 at 10:00 CET (the "EGM").The notice of the EGM, including the shareholders' proposed agenda item regarding Board election, is attached to this notice and available on https://cavendishh2.com/, and will be sent to Cavendish's shareholders with known addresses. The Company's Nomination

Q1 Interim Report July 2024 – September 2024

OPENING REMARKS   The first quarter of the fiscal year 2024-2025 has been productive for Hamlet Biopharma. As summarized in the recently published Annual Report 2023-2024, significant clinical progress has been made in three different clinical areas - bladder cancer, recurrent acute cystitis and bladder pain. We are proud to have taken the investigational new drug Alpha1H from discovery, through the drug development process to the clinic. We are also proud to have identified new clinical indications for the IL-1 receptor antagonist anakinra, based on scientific precision and the

Viking Line named Finnish Security Organization of the Year

Participants in the Finnish security industry have named Viking Line Security Organization of the Year 2024. According to the jury, the company has significantly improved security on its vessels both for passengers and staff and has been a trailblazer in many projects that promote security. For example, Viking Line was the first shipping company in the world to instal an automated radar system to monitor respiration in its vessels’ detention facilities.Members of the Finnish security industry and the trade publication Turvallisuus & Riskienhallinta (’Safety & Risk Management’) named Viking

Well-executed clinical introduction of EndoDrill[®] GI at Sahlgrenska University Hospital in Sweden

The cancer diagnostics company BiBBInstruments AB ("BiBB" and the “Company”), the developer of EndoDrill[®], the world's first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first clinical tissue sampling procedures with EndoDrill[® ]GI at Sahlgrenska University Hospital in Gothenburg have been successfully completed. Expanded market studies at several hospitals in Europe and the USA are an important part of the Company's strategy and represent the first step in the launch of EndoDrill[®] GI.“It was very rewarding to be present and witness users from yet

BioStock: Curasight announces brain cancer as initial target for uTREAT

Brain cancer will be the first indication for Curasight’s uTREAT therapy. The company’s decision to choose aggressive brain cancer for a fast single indications trial is backed by promising preclinical and clinical results demonstrating the potential of its uPAR-targeted technologies in neuro-oncology. Curasight aims to begin dosing the first patient in a clinical trial by the end of the second quarter of 2025. BioStock contacted CEO Ulrich Krasilnikoff to learn more.Read the full article at biostock.se: https://www.biostock.se/en/2024/11/curasight-announces-brain-cancer-as-initial-

Lappland Guldprospektering discovers a high-grade mineralized zone of 9 meters with an average of 8.5 Grams Au/ton in its initial drilling Program

Lappland Guldprospektering’s summer drilling provided valuable information through several observations of solid gold. Drill hole 4 indicated a gold-rich zone of 9 meters between 39 and 48 meters with an average grade of 8.5 g/t, including 0.5 meters at 140 g/t. This zone is part of a longer gold-mineralized position with relatively low gold content. This drill hole (no. 4) also revealed a near-surface position between 9.1 meters and 11.3 meters with a gold content of 4.5 g per ton.The drillings indicate a gold-rich zone that may be an extension of previous drilling hits. In the remaining

Interim Report Q3 2024 (January - September)

July – September 2024- Revenue MSEK 141 (157)- Order intake and Procurement Awards MSEK 95 (145)- Operating profit (EBITDA) MSEK 12.0 (19.2)- Operating profit (EBIT) MSEK 1.1 (8.3 )- Total Comprehensive income MSEK -18.5 (-2.0)- Earnings per share, before and after dilution (SEK) -0.71 (0.69)- Cash flow from operating activities MSEK 8.9 (4.1) January – September 2024- Revenue MSEK 433 (403)- Order intake and Procurement Awards MSEK 831 (541)- Operating profit (EBITDA) MSEK 40.3 (39.9)- Operating profit (EBIT) MSEK 7.8 (5.3)- Total Comprehensive income MSEK 4.7 (12.

Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas—Inherited Gastrointestinal Cancers

PHILADELPHIA (USA) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, will present results from the recently completed model-development study of the company’s next-generation test at the 2024 annual meeting of the Collaborative Group of Americas—Inherited Gastrointestinal Cancers (CGA-IGC).   The Scientific Committee of the CGA-IGC evaluated and accepted Immunovia’s abstract, which reports outcomes from the company’s model-development study, for presentation at the meeting. Immunovia’s submission was also recognized for inclusion in the Henry Lynch

Last day of trading in unit rights in Crunchfish

Today, November 15, 2024, is the last day of trading in unit rights issued in connection with Crunchfish AB’s (”Crunchfish” or the ”Company”) rights issue of units with preferential rights for existing shareholders of approximately SEK 57 million before issue costs, which was resolved by the board of directors on September 20, 2024, and approved by the Extraordinary General Meeting held on October 24, 2024 (the “Rights Issue”). Unit rights that are not sold no later than today, November 15, 2024, or exercised for subscription of units no later than November 20, 2024, will expire without value.

Interim report January–September 2024

JULY– SEPTEMBER 2024 · Net sales amounted to MSEK 269.4 (304.2). · Net sales declined 11% (-4). · Adjusted EBIT amounted to MSEK 0.4 (5.3). · The adjusted EBIT margin amounted to 0.1% (1.7). · Non-recurring impairment of MSEK 48.4 was charged to EBIT. · Net income was MSEK -41.9 (-9.4). · Loss per share amounted to SEK -0.84 (-0.19).   JANUARY– SEPTEMBER 2024 · Net sales amounted to MSEK 868.3 (1,060.4). · Net sales declined 18% (+1). · Adjusted EBIT amounted to MSEK -10.5 (51.2). · The adjusted EBIT margin amounted to -1.2% (4.8). · Non-

Peptonic Medical publishes an operational update

Today, Peptonic Medical AB ("Peptonic") publishes an operational update outlining the strategic actions and initiatives implemented and planned for the year. These efforts are expected to position the company to achieve positive cash flow in the second half of 2025.Expansion in the USA. After more than six months of preparation, including the development of a new e-commerce platform, the creation of sales and marketing strategies, and initiating influencer partnerships, Peptonic is set to launch an extensive digital marketing campaign for VagiVital in the U.S. in November. This campaign

Respiratorius CEO to BioStock: “We continue to reduce risk in the project”

The partnering process continues for Respiratorius, which recently released the report for the third quarter. The US patent has been approved and the focus is now on refining the VAL001 project, with a particular focus on the regulatory aspects. – We have a clear strategy to clarify and strengthen the company’s values as well as a clear regulatory strategy, says Johan Drott to BioStock.Read the full article at biostock.se : https://www.biostock.se/en/2024/11/respiratorius-ceo-we-continue-to-reduce-risk-in-the-project/ This is a press release from

GARO recruits Jonas Klarén as new President and CEO

GARO has recruited Jonas Klarén as its new President and CEO. Jonas Klarén’s most recent position was as CEO of Infratek Sverige AB, which is part of the French VINCI Group, listed on the Paris Stock Exchange. Jonas has extensive experience from the energy and power supply industry and has successfully developed Infratek within VINCI Energies. He also worked at ABB earlier in his career and he holds an M.Sc. in Electric Engineering from Chalmers University of Technology in Gothenburg. Jonas will assume his position as President and CEO as soon as possible, but in six months at the latest.

Ruukki Construction completes major investment in Finland: more sustainable roofs more efficiently

Ruukki ConstructionPress release15 November 2024 at 9 am EETRuukki Construction, part of SSAB, is today celebrating the opening of the new roof profile production line in Vimpeli, Finland. The production line for Ruukki Classic®, Ruukki Classic® LowCarbon and Ruukki® Trendic profiles is the largest single machine investment in the project announced in December 2021. The improvements will result in new, better and more sustainable roofing products more efficiently for Ruukki's installation partners as well as for house builders and renovators. In Scandinavia, the residential roofing

Esmaeilzadeh Holding publishes net asset value as of 31 October 2024

As of 31 October 2024, the net asset value for Esmaeilzadeh Holding AB (publ) was SEK 6.52 billion (SEK 6.54 billion as of 30 September 2024), corresponding to a net asset value per share of SEK 8,301 (SEK 8,332 as of 30 September 2024).[1]  For further information, please contact: Mikael Ericson, CEO mikael.ericson@ehab.group For press related enquires, please contact: Michaela Abercrombie Simpson, Head of Communications Phone: +46 736 301 403 The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on 15

Gradientech presented QuickMIC® performance data at the 17th National Microbiology Conference in Romania

The diagnostics company Gradientech announces the presentation of newly published outstanding performance data on QuickMIC® at the 17th National Conference of Microbiology and Epidemiology in Iași, Romania, 7-9 November 2024.The national conference in Iași brought together experts in infectious diseases and clinical microbiology from across Romania to discuss urgent public health challenges. The sessions addressed various topics, including innovative diagnostics and infection prevention strategies. The QuickMIC® system was showcased by Biomedica Medizinprodukte GmbH, Gradientech’s

There are no items matching the current filter
There are no more items matching the current filter
Back to top